Drugs / Ferric maltol
Ferric maltol
also known as
Feraccru · Accrufer · Ferracru · Iron maltol · Maltol ferrico · Maltol ferrique · ST10 · ST10-021
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | ACCRUFER | — | 2025-12-19 | fda.gov ↗ |
| Approved | US (FDA) | ACCRUFER | — | 2019-07-25 | fda.gov ↗ |
| Approved | EU (EMA) | Feraccru | — | 2016-02-18 | europa.eu ↗ |
Trials 10 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT04626414 Comparator | Sep → Nov 2020 | iron deficiency anemia | Shield Therapeutics | Completed | No outcome recorded |
| Phase 1 | NCT03181451 Comparator | Mar 2017 → Mar 2018 | iron deficiency anemia | Shield Therapeutics | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07308769 Comparator | Dec 2025 → May 2026 overdue | iron deficiency anemia | Pharmanutra S.p.a. | Recruiting | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ferric Maltol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02680756 ↗ |
| Known as | Accrufer | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298110 ↗ |
| Known as | Feraccru | “Treatment with Feraccru® 30 mg hard capsules (Ferric maltol 30 mg).” NCT05697211 ↗3“Treatment with Feraccru® 30 mg hard capsules (Ferric maltol 30 mg).” NCT03371173 ↗ “Ferric Maltol (Feraccru®), 30 mg elemental iron per capsule” NCT07308769 ↗ “Feraccru® 30 mg hard capsules will be used.” NCT03774615 ↗ |
| Known as | Ferracru | “a newer oral iron preparation - ferric maltol (Ferracru) has been found to be better tolerated and more efficacious than ferrous iron.” NCT05177484 ↗ |
| Known as | Iron maltol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298110 ↗ |
| Known as | Maltol ferrico | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298110 ↗ |
| Known as | Maltol ferrique | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298110 ↗ |
| Known as | ST10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01352221 ↗ |
| Known as | ST10-021 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01340872 ↗ |
| Modality | Small molecule | — CHEMBL4298110 ↗ |
| Route | Oral | “30 mg capsules to be taken orally twice a day for 12 weeks” NCT01340872 ↗ |